The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model
Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosion...
Saved in:
Published in | Allergy, asthma & immunology research Vol. 9; no. 2; pp. 169 - 176 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
01.03.2017
대한천식알레르기학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2092-7355 2092-7363 |
DOI | 10.4168/aair.2017.9.2.169 |
Cover
Abstract | Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model.
Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods.
In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF.
This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. |
---|---|
AbstractList | Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model.PURPOSELipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model.Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods.METHODSMice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods.In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF.RESULTSIn the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF.This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.CONCLUSIONSThis study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model. Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. Purpose: Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPSinduced non-eosionophilic rhinitis model. Methods: Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. Results: In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPSdose- dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. Conclusions: This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. KCI Citation Count: 8 Purpose Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model. Methods Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-[mu]g LPS treatment group, and 10-[mu]g LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 [mu]g of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. Results In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-[gamma]) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-[gamma]) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. Conclusions This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. |
Author | Kim, Ji-Hye Kim, Eun Hee Mo, Ji-Hun Bae, Jun-Sang |
AuthorAffiliation | 2 Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea 1 Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea |
AuthorAffiliation_xml | – name: 1 Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea – name: 2 Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea |
Author_xml | – sequence: 1 givenname: Jun-Sang surname: Bae fullname: Bae, Jun-Sang organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea., Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea – sequence: 2 givenname: Ji-Hye surname: Kim fullname: Kim, Ji-Hye organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea – sequence: 3 givenname: Eun Hee surname: Kim fullname: Kim, Eun Hee organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea – sequence: 4 givenname: Ji-Hun surname: Mo fullname: Mo, Ji-Hun organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28102062$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002202376$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqNkd1rFDEUxYNUbK39A3yRedSHGfMxuUlexFL8WFgRlvU5ZPPhxs5O1mS20P_eTLctKgjel3tDzvlx4DxHJ2MaPUIvCe56AvKtMTF3FBPRqY52BNQTdEaxoq1gwE4eb85P0UUpP3AdRvoe-mfolEqCKQZ6ht6vt75ZpcE3KTSLZUtEE8fGNMu4T_s03BZj7dbk6Hy7GN3BetestnGMUyzNl-T88AI9DWYo_uJ-n6NvHz-srz63y6-fFleXy9b2AFPbSyfMJvTEsxqDsQ0TQLEFLgPD1AQuDWNgnQne9MIFr8BQ4RSw-txwwc7RmyN3zEFf26iTiXf7e9LXWV-u1gtduQCcVO27o3Z_2Oy8s36cshn0Psedybd3zj9_xritnBvNKQAhM-D1PSCnnwdfJr2LxfphMKNPh6KJVEQKqdT_SIFwAVzIKn31e6zHPA9tVIE4CmxOpWQftI2TmWKaU8ZBE6zn6vVcvZ6r10pTXauvTvKX8wH-b88v4Ravug |
CitedBy_id | crossref_primary_10_1016_j_biopha_2018_07_093 crossref_primary_10_3892_etm_2022_11116 crossref_primary_10_1089_jir_2021_0183 crossref_primary_10_3389_fimmu_2017_01835 crossref_primary_10_3389_fmicb_2022_1002084 crossref_primary_10_1002_clt2_12047 crossref_primary_10_1051_bioconf_202411102023 crossref_primary_10_1186_s12950_024_00415_9 crossref_primary_10_1021_acsfoodscitech_3c00351 crossref_primary_10_4168_aair_2022_14_1_5 crossref_primary_10_1177_1945892421998143 crossref_primary_10_1089_jmf_2020_4750 crossref_primary_10_3892_etm_2019_7631 crossref_primary_10_1016_j_bjorl_2020_05_020 crossref_primary_10_1016_j_intimp_2018_02_006 crossref_primary_10_1016_j_intimp_2023_110730 crossref_primary_10_4049_immunohorizons_2400061 crossref_primary_10_1002_kjm2_12215 crossref_primary_10_1111_all_15384 crossref_primary_10_1177_1945892420936587 crossref_primary_10_1186_s12860_018_0152_5 crossref_primary_10_1016_j_ejphar_2020_173564 crossref_primary_10_21053_ceo_2019_02005 crossref_primary_10_1016_j_jhazmat_2024_135800 crossref_primary_10_1186_s12890_021_01798_8 crossref_primary_10_1016_j_intimp_2021_108279 crossref_primary_10_1038_s41598_020_80483_y crossref_primary_10_1177_19458924231152683 crossref_primary_10_1016_j_fct_2024_114435 |
Cites_doi | 10.1007/s10067-005-1081-1 10.1016/j.imlet.2004.01.014 10.1164/ajrccm.160.5.9806170 10.1016/j.lfs.2006.12.038 10.1177/194589240602000219 10.4168/aair.2011.3.3.199 10.1046/j.1365-2222.2001.01081.x 10.1046/j.1365-2222.2001.01129.x 10.1513/pats.200808-087RM 10.1093/cvr/cvq397 10.1034/j.1399-3003.2000.15e28.x 10.1038/nm1105 10.1371/journal.pone.0058892 10.1172/JCI21275 10.4049/jimmunol.0901566 10.1016/j.jaci.2006.01.039 10.1111/j.1348-0421.1986.tb03015.x 10.2332/allergolint.R-07-160 10.1186/1476-7961-9-3 10.1007/s10753-012-9475-0 10.4049/jimmunol.168.6.3017 10.4049/jimmunol.181.6.4089 |
ContentType | Journal Article |
Copyright | Copyright © 2017 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2017 |
Copyright_xml | – notice: Copyright © 2017 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2017 |
DBID | AAYXX CITATION NPM 7X8 7T5 7U7 C1K H94 5PM ACYCR |
DOI | 10.4168/aair.2017.9.2.169 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic PubMed AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2092-7363 |
EndPage | 176 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1336651 PMC5266111 28102062 10_4168_aair_2017_9_2_169 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAKDD AAYXX ACPRK ADBBV ADRAZ AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU E3Z EF. F5P GX1 HYE KQ8 M48 O5R O5S OK1 PGMZT RPM NPM 7X8 7T5 7U7 C1K H94 5PM ACYCR |
ID | FETCH-LOGICAL-c466t-48d7abf41e303133b37620c658f302af58a336cdafea47dfe96a27d963a47b573 |
IEDL.DBID | M48 |
ISSN | 2092-7355 |
IngestDate | Sun Mar 09 07:54:47 EDT 2025 Thu Aug 21 18:22:02 EDT 2025 Thu Jul 10 18:33:26 EDT 2025 Fri Jul 11 08:35:06 EDT 2025 Thu Apr 03 07:06:30 EDT 2025 Fri Jul 04 01:06:56 EDT 2025 Thu Apr 24 23:03:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | interleukin-17 Rhinitis lipopolysaccharide vascular endothelial growth factor |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c466t-48d7abf41e303133b37620c658f302af58a336cdafea47dfe96a27d963a47b573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-SER000002443.2017.9.2.008 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2017.9.2.169 |
PMID | 28102062 |
PQID | 1861576578 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1336651 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5266111 proquest_miscellaneous_1891878991 proquest_miscellaneous_1861576578 pubmed_primary_28102062 crossref_citationtrail_10_4168_aair_2017_9_2_169 crossref_primary_10_4168_aair_2017_9_2_169 |
PublicationCentury | 2000 |
PublicationDate | 2017-03-01 |
PublicationDateYYYYMMDD | 2017-03-01 |
PublicationDate_xml | – month: 03 year: 2017 text: 2017-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Allergy, asthma & immunology research |
PublicationTitleAlternate | Allergy Asthma Immunol Res |
PublicationYear | 2017 |
Publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 대한천식알레르기학회 |
Publisher_xml | – name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease – name: 대한천식알레르기학회 |
References | Lavinskiene (10.4168/aair.2017.9.2.169_ref5) 2012; 35 Tamura (10.4168/aair.2017.9.2.169_ref16) 1986; 30 Tsunematsu (10.4168/aair.2017.9.2.169_ref17) 2007; 80 Lee (10.4168/aair.2017.9.2.169_ref8) 2004; 10 Hussain (10.4168/aair.2017.9.2.169_ref14) 2001; 31 Lindén (10.4168/aair.2017.9.2.169_ref7) 2000; 15 Kim (10.4168/aair.2017.9.2.169_ref21) 2009; 183 Numasaki (10.4168/aair.2017.9.2.169_ref10) 2004; 93 McKinley (10.4168/aair.2017.9.2.169_ref6) 2008; 181 Mo (10.4168/aair.2017.9.2.169_ref15) 2006; 20 Holgate (10.4168/aair.2017.9.2.169_ref3) 2006; 117 Saito (10.4168/aair.2017.9.2.169_ref12) 2002; 168 Albano (10.4168/aair.2017.9.2.169_ref18) 2013; 8 Hayashi (10.4168/aair.2017.9.2.169_ref20) 2004; 114 Mo (10.4168/aair.2017.9.2.169_ref9) 2011; 3 Kämpe (10.4168/aair.2017.9.2.169_ref4) 2011; 9 Fahy (10.4168/aair.2017.9.2.169_ref2) 2009; 6 Ryu (10.4168/aair.2017.9.2.169_ref11) 2006; 25 Jatakanon (10.4168/aair.2017.9.2.169_ref1) 1999; 160 Oboki (10.4168/aair.2017.9.2.169_ref19) 2008; 57 Hata (10.4168/aair.2017.9.2.169_ref22) 2011; 90 Hellings (10.4168/aair.2017.9.2.169_ref13) 2001; 31 15378055 - Nat Med. 2004 Oct;10(10):1095-103 19786548 - J Immunol. 2009 Oct 15;183(8):5113-20 21156823 - Cardiovasc Res. 2011 May 1;90(2):364-72 10853869 - Eur Respir J. 2000 May;15(5):973-7 16163444 - Clin Rheumatol. 2006 Feb;25(1):16-20 16522446 - J Allergy Clin Immunol. 2006 Mar;117(3):496-506; quiz 507 17300813 - Life Sci. 2007 Mar 20;80(15):1388-94 10556116 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532-9 21738886 - Allergy Asthma Immunol Res. 2011 Jul;3(3):199-204 11422139 - Clin Exp Allergy. 2001 May;31(5):782-90 19387026 - Proc Am Thorac Soc. 2009 May 1;6(3):256-9 21255397 - Clin Mol Allergy. 2011 Jan 21;9(1):3 15134897 - Immunol Lett. 2004 Apr 30;93(1):39-43 18768865 - J Immunol. 2008 Sep 15;181(6):4089-97 3796321 - Microbiol Immunol. 1986;30(9):883-91 16686392 - Am J Rhinol. 2006 Mar-Apr;20(2):212-8 18427165 - Allergol Int. 2008 Jun;57(2):121-34 15254594 - J Clin Invest. 2004 Jul;114(2):270-9 11884474 - J Immunol. 2002 Mar 15;168(6):3017-23 11467996 - Clin Exp Allergy. 2001 Jul;31(7):1048-59 23573194 - PLoS One. 2013;8(4):e58892 22576978 - Inflammation. 2012 Aug;35(4):1600-9 |
References_xml | – volume: 25 start-page: 16 year: 2006 ident: 10.4168/aair.2017.9.2.169_ref11 publication-title: Clin Rheumatol doi: 10.1007/s10067-005-1081-1 – volume: 93 start-page: 39 year: 2004 ident: 10.4168/aair.2017.9.2.169_ref10 publication-title: Immunol Lett doi: 10.1016/j.imlet.2004.01.014 – volume: 160 start-page: 1532 year: 1999 ident: 10.4168/aair.2017.9.2.169_ref1 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.160.5.9806170 – volume: 80 start-page: 1388 year: 2007 ident: 10.4168/aair.2017.9.2.169_ref17 publication-title: Life Sci doi: 10.1016/j.lfs.2006.12.038 – volume: 20 start-page: 212 year: 2006 ident: 10.4168/aair.2017.9.2.169_ref15 publication-title: Am J Rhinol doi: 10.1177/194589240602000219 – volume: 3 start-page: 199 year: 2011 ident: 10.4168/aair.2017.9.2.169_ref9 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2011.3.3.199 – volume: 31 start-page: 782 year: 2001 ident: 10.4168/aair.2017.9.2.169_ref13 publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.2001.01081.x – volume: 31 start-page: 1048 year: 2001 ident: 10.4168/aair.2017.9.2.169_ref14 publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.2001.01129.x – volume: 6 start-page: 256 year: 2009 ident: 10.4168/aair.2017.9.2.169_ref2 publication-title: Proc Am Thorac Soc doi: 10.1513/pats.200808-087RM – volume: 90 start-page: 364 year: 2011 ident: 10.4168/aair.2017.9.2.169_ref22 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvq397 – volume: 15 start-page: 973 year: 2000 ident: 10.4168/aair.2017.9.2.169_ref7 publication-title: Eur Respir J doi: 10.1034/j.1399-3003.2000.15e28.x – volume: 10 start-page: 1095 year: 2004 ident: 10.4168/aair.2017.9.2.169_ref8 publication-title: Nat Med doi: 10.1038/nm1105 – volume: 8 start-page: e58892 year: 2013 ident: 10.4168/aair.2017.9.2.169_ref18 publication-title: PLoS One doi: 10.1371/journal.pone.0058892 – volume: 114 start-page: 270 year: 2004 ident: 10.4168/aair.2017.9.2.169_ref20 publication-title: J Clin Invest doi: 10.1172/JCI21275 – volume: 183 start-page: 5113 year: 2009 ident: 10.4168/aair.2017.9.2.169_ref21 publication-title: J Immunol doi: 10.4049/jimmunol.0901566 – volume: 117 start-page: 496 year: 2006 ident: 10.4168/aair.2017.9.2.169_ref3 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2006.01.039 – volume: 30 start-page: 883 year: 1986 ident: 10.4168/aair.2017.9.2.169_ref16 publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1986.tb03015.x – volume: 57 start-page: 121 year: 2008 ident: 10.4168/aair.2017.9.2.169_ref19 publication-title: Allergol Int doi: 10.2332/allergolint.R-07-160 – volume: 9 start-page: 3 year: 2011 ident: 10.4168/aair.2017.9.2.169_ref4 publication-title: Clin Mol Allergy doi: 10.1186/1476-7961-9-3 – volume: 35 start-page: 1600 year: 2012 ident: 10.4168/aair.2017.9.2.169_ref5 publication-title: Inflammation doi: 10.1007/s10753-012-9475-0 – volume: 168 start-page: 3017 year: 2002 ident: 10.4168/aair.2017.9.2.169_ref12 publication-title: J Immunol doi: 10.4049/jimmunol.168.6.3017 – volume: 181 start-page: 4089 year: 2008 ident: 10.4168/aair.2017.9.2.169_ref6 publication-title: J Immunol doi: 10.4049/jimmunol.181.6.4089 – reference: 16522446 - J Allergy Clin Immunol. 2006 Mar;117(3):496-506; quiz 507 – reference: 10556116 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532-9 – reference: 17300813 - Life Sci. 2007 Mar 20;80(15):1388-94 – reference: 11422139 - Clin Exp Allergy. 2001 May;31(5):782-90 – reference: 19387026 - Proc Am Thorac Soc. 2009 May 1;6(3):256-9 – reference: 15378055 - Nat Med. 2004 Oct;10(10):1095-103 – reference: 22576978 - Inflammation. 2012 Aug;35(4):1600-9 – reference: 18768865 - J Immunol. 2008 Sep 15;181(6):4089-97 – reference: 21156823 - Cardiovasc Res. 2011 May 1;90(2):364-72 – reference: 11467996 - Clin Exp Allergy. 2001 Jul;31(7):1048-59 – reference: 15134897 - Immunol Lett. 2004 Apr 30;93(1):39-43 – reference: 21738886 - Allergy Asthma Immunol Res. 2011 Jul;3(3):199-204 – reference: 16686392 - Am J Rhinol. 2006 Mar-Apr;20(2):212-8 – reference: 11884474 - J Immunol. 2002 Mar 15;168(6):3017-23 – reference: 10853869 - Eur Respir J. 2000 May;15(5):973-7 – reference: 3796321 - Microbiol Immunol. 1986;30(9):883-91 – reference: 19786548 - J Immunol. 2009 Oct 15;183(8):5113-20 – reference: 21255397 - Clin Mol Allergy. 2011 Jan 21;9(1):3 – reference: 23573194 - PLoS One. 2013;8(4):e58892 – reference: 15254594 - J Clin Invest. 2004 Jul;114(2):270-9 – reference: 18427165 - Allergol Int. 2008 Jun;57(2):121-34 – reference: 16163444 - Clin Rheumatol. 2006 Feb;25(1):16-20 |
SSID | ssj0000314464 |
Score | 2.240017 |
Snippet | Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a... Purpose Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish... Purpose: Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 169 |
SubjectTerms | Original 내과학 |
Title | The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28102062 https://www.proquest.com/docview/1861576578 https://www.proquest.com/docview/1891878991 https://pubmed.ncbi.nlm.nih.gov/PMC5266111 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002202376 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Allergy, 2017, Asthma & Immunology Research, 9(2), , pp.169-176 |
journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: DYU dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.cabidigitallibrary.org/product/zd providerName: CAB International – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: 5-W dateStart: 20090101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2092-7363 dateEnd: 20250430 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7355 databaseCode: M48 dateStart: 20091001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9swEBZtB2Mvo93PrGvRxtjDQJ4l2ZL9tI3S0o5mD2WB7klIstSaBjtNUlj_-93FTlhGKHsytmVzOp1033HSfYR8UFEWTkVAbmWILPMxYw5wAMtCjNpZbVONB5yHP9TpKPt-mV9ukWX2vFfgbGNoh3xSo-k4-X17_wUmPODXBOBE8dnaGit7cp2UiUi4Kj9ObhnySmH-tSfZ2CaPwFcJtPthHwAs1mqJ8RCmnkVagsDgfbvU5-Yfrzmv7WYaN-HSf7dX_uWvTnbJ0x5o0m-dZeyRrdA8I4-HfSr9OfkKBkIv2nGgbaRn54xrWjfU0vN6grwJ9zPr8URWXQWG9B4-VPTiusatRjOKBGrjF2R0cvzz6JT1dArMZ0rNWVZU2rqY8SCxYKN0sLaI1AMEiTIVNuaFlVL5ysZgM13FUCordAUzFG5druVLstO0TXhNKD50AdCCzAES5s5lXnJellVMhdNcDEi61JPxfa1xpLwYG4g5ULUGVWtQtaY0woBqB-TT6pNJV2jjocbvQfnmxtcGy2Pj9ao1N1MDQcCZgb4plfMBebccGwNzBhMhtgnt3czwAnCcVrBYPdSm5IWGaBT-86obz5VcogBYliropl4b6VUDFGr9TVNfL2p35wiIOH_zH7LtkyfY527D21uyM5_ehQNAQHN3CNj_1-hwYcp_AET7A2M |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+IL-17+in+a+Lipopolysaccharide-Induced+Rhinitis+Model&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Bae%2C+Jun+Sang&rft.au=Kim%2C+Ji+Hye&rft.au=Kim%2C+Eun+Hee&rft.au=Mo%2C+Ji+Hun&rft.date=2017-03-01&rft.issn=2092-7355&rft.volume=9&rft.issue=2&rft.spage=169&rft_id=info:doi/10.4168%2Faair.2017.9.2.169&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon |